As seen in Figure 5A, binding of anti-HER2/neu–sensitized (trastuzumab IgE) ADMC to SK-BR-3 cells induced significant cell death of the breast cancer cells as assessed by the uptake and visualization (red) of the PI in the SK-BR-3 cells but not the ADMC. This evidence concerns the gene IGHE and breast carcinoma.